Labixiaoxin Snacks Group Ltd. (1262) AI Stock Analysis

• Market Cap: HK$393.15M
• Dividend Yield: N/A
• Average Volume (3M): 22.81K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.14
• Revenue Growth: 4.72%
• EPS Growth: 79.88%
• Country: HK
• Employees: 860
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.01
• Shares Outstanding: 218,416,090
• 10 Day Avg. Volume: 47,780
• 30 Day Avg. Volume: 22,813
• PEG Ratio: -0.01
• Price to Book (P/B): 1.31
• Price to Sales (P/S): 0.32
• P/FCF Ratio: -8.21
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 40 Underperform
• Price Target: HK$2.00 ▲(8.11% Upside)

The overall stock score is primarily influenced by weak financial performance and valuation concerns. The company's high leverage and negative profitability metrics are significant risks. Technical analysis indicates bearish momentum, further weighing on the score. The lack of earnings call and corporate events data means these factors do not influence the score.

Labixiaoxin Snacks Group Ltd. Business Overview & Revenue Model

Company Description

Labixiaoxin Snacks Group Ltd. (1262) is a leading player in the snack food industry, primarily engaged in the production and distribution of a diverse range of snack products. Based in China, the company operates across various sectors, focusing on the manufacturing of healthy and convenient snack options, including nuts, dried fruits, and other packaged snacks. Labixiaoxin is committed to innovation and quality, catering to the growing demand for healthier snack choices among consumers.

How the Company Makes Money

Labixiaoxin Snacks Group Ltd. generates revenue through multiple key streams, primarily from the sale of its snack products to retailers, wholesalers, and directly to consumers. The company benefits from a diversified product portfolio, which allows it to target different market segments and adapt to changing consumer preferences. Significant revenue is derived from partnerships with major retailers and online platforms, enhancing its distribution reach. Additionally, Labixiaoxin invests in marketing and branding efforts to strengthen its market presence and foster customer loyalty, which further contributes to its earnings. The company also explores opportunities in international markets, expanding its customer base and enhancing revenue potential.

Labixiaoxin Snacks Group Ltd. Financial Statement Overview

Summary

Labixiaoxin Snacks Group Ltd. exhibits revenue growth but faces challenges in profitability and cash flow generation. High leverage and declining equity are key risks, while operational inefficiencies further pressure financial stability. Strategic improvements are necessary to enhance financial health.

Income Statement

The company shows some revenue growth with a 13.39% increase from 2023 to 2024, but profitability is a concern given the negative net profit margin of -10.79% for 2024. The gross profit margin is 27.06%, indicating some cost control, but negative EBIT and EBITDA margins suggest operational inefficiencies.

Balance Sheet

The high debt-to-equity ratio of 2.13 in 2024 indicates significant leverage, posing financial stability risks. The equity ratio is 27.02%, showing moderate asset financing by equity, but a declining trend in stockholders' equity suggests weakened financial health.

Cash Flow

The absence of positive operating cash flow and free cash flow in 2024 is concerning, highlighting potential liquidity issues. Previous periods showed improvement in free cash flow, but the lack of data for 2024 prevents a comprehensive analysis.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	888.87M	866.67M	764.38M	684.26M	648.07M	508.84M
Gross Profit	230.57M	234.62M	218.94M	244.19M	224.28M	166.54M
EBITDA	9.88M	-35.72M	-46.04M	658.00K	74.44M	108.73M
Net Income	-47.29M	-93.46M	-104.75M	-75.33M	-65.20M	-29.40M
Balance Sheet
Total Assets	837.13M	793.84M	810.91M	977.31M	1.29B	1.53B
Cash, Cash Equivalents and Short-Term Investments	47.48M	52.50M	44.32M	71.88M	80.57M	258.84M
Total Debt	461.94M	456.40M	451.27M	512.44M	565.59M	690.74M
Total Liabilities	620.09M	579.32M	588.35M	650.00M	887.41M	1.06B
Stockholders Equity	217.04M	214.52M	222.56M	327.31M	402.64M	467.84M
Cash Flow
Free Cash Flow	-16.58M	-34.23M	55.42M	-4.98M	-156.86M	-21.57M
Operating Cash Flow	37.98M	31.53M	88.64M	15.46M	-135.29M	-12.47M
Investing Cash Flow	-50.91M	-65.54M	-32.89M	55.94M	113.42M	300.93M
Financing Cash Flow	25.54M	42.19M	-83.31M	-80.09M	-156.41M	-54.46M

Labixiaoxin Snacks Group Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.85
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1262, the sentiment is Negative. The current price of 1.85 is above the 20-day moving average (MA) of 1.85, below the 50-day MA of 1.89, and above the 200-day MA of 1.77, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 32.24 is Neutral, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1262.

Labixiaoxin Snacks Group Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1285	72 Outperform	HK$477.25M	9.97	4.62%	13.04%	2.82%	-22.62%
2317	72 Outperform	HK$974.55M	8.16	5.08%	10.44%	-1.19%	-9.05%
1837	68 Neutral	HK$2.41B	10.83	13.72%	3.60%	11.89%	27.80%
1767	68 Neutral	HK$285.00M	10.80	5.48%	0.81%	5.43%	-25.42%
1583	63 Neutral	$1.01B	96.40	0.79%	0.00%	-1.70%	104.41%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
1262	40 Underperform	HK$393.15M	―	-23.87%	―	4.72%	79.88%

Labixiaoxin Snacks Group Ltd. Corporate Events

Labixiaoxin Snacks Group Ltd. Reports Positive Interim Results for 2025

Labixiaoxin Snacks Group Ltd. announced its unaudited consolidated interim results for the six months ending June 30, 2025, showing a revenue increase of 4.5% to RMB 516 million compared to the same period in 2024. The company reported a turnaround from a loss to a profit, with a net profit of RMB 2.5 million, indicating improved operational efficiency and cost management, despite a slight decrease in gross profit margin. This financial performance suggests a positive shift in the company’s market position and potential growth prospects, benefiting stakeholders.

The most recent analyst rating on (HK:1262) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Labixiaoxin Snacks Group Ltd. stock, see the HK:1262 Stock Forecast page.

Labixiaoxin Snacks Group Ltd. Schedules Board Meeting for Interim Results

Labixiaoxin Snacks Group Ltd. has announced that its board of directors will meet on August 29, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The board will also consider recommending an interim dividend, reflecting the company’s ongoing commitment to shareholder value.

Labixiaoxin Snacks Group Ltd. Announces Positive Profit Alert for H1 2025

Labixiaoxin Snacks Group Ltd. has announced a positive profit alert, expecting to record a profit after tax of approximately RMB2.0 million for the first half of 2025, compared to a loss of RMB43.6 million in the same period of 2024. This improvement is attributed to reduced advertising and promotion expenses and lower allowances for expected credit losses.